So far, the data gathered is from a Phase 2 study with 11 people in it (published a year ago last June).
https://www.celltherapyjournal.org/article/S1465-3249(18)30471-7/fulltext
I doubt...
Type: Posts; User: GRAMMY
So far, the data gathered is from a Phase 2 study with 11 people in it (published a year ago last June).
https://www.celltherapyjournal.org/article/S1465-3249(18)30471-7/fulltext
I doubt...
This is not a new sudden revelation. Due to the nature of the 20 years of research funding the decision was made to try and treat their own citizens first. I don't know why you keep bumping up the...
NC1 can already be administered to many of the 40,000 spinal injuries in Spain, a number that grows with almost 1,000 new cases annually. But at the moment it will begin in its first two years with...
OPC is for an acute stage up to 42 days after injury. They do not want to perform well in the chronic niche in rodents.
Posted last May...
http://sci.rutgers.edu/forum/showthread.php?264598-Article-about-Dr-Silver-s-injectable-peptide
The whole picture emerges when the data is compiled at the end of the clinical trial series. That's why the FDA requires them before a therapy goes to market for people and insurance companies to...
NJ Commission on Spinal Cord Research funds GDF10 research project. LINK
I don't think we'll know until it's tested in conjunction with something else in humans. It would appear to me that's exactly where this is headed so we can get those answers.
The aim is not to restore the ability to walk normally for patients, but rather to allow them to walk 30 to 45 minutes on a treadmill.
It is the researcher Pierre Guertin who invented the Spinalon....
You're welcome. Let's hope this becomes a viable option when someone sustains a SCI.
Everything I pull up on Yamashita's papers with various diseases and injury models, it indicates to me that this would be an acute time frame option.
CDRPA got passed and was signed into law by President Obama in 2009 (tucked into a huge public land bill). Alas, the legislation was never funded; CDRPA died on the vine.
http://sci.rutgers.edu/forum/showthread.php?262704-RENETX-Update&p=1880559&viewfull=1#post1880559
https://medicine.yale.edu/lab/strittmatter/
http://sci.rutgers.edu/forum/showthread.php?262704-RENETX-Update&p=1878432&viewfull=1#post1878432
I don't know what an Amberly is, but Biocellerator is just another overseas clinic (Columbia this time) selling cells that have not gotten FDA approval in the US. They claim to repair just about...
This is the list. https://u2fp.org/working-2-walk/speakers-agenda-2019.html
And you can add the fact that those involved in initiating the startup company have a direct connection to spinal cord injury.
https://spinalcordresearchandadvocacy.wordpress.com/2015/10/05/the-role-of-peripheral-nerve-surgery-in-restoring-motor-control-following-neurotrama-dr-justin-m-brown/
...
https://spinalcordresearchandadvocacy.wordpress.com/2014/11/24/advances-in-peripheral-nerve-surgery-and-applicability-to-spinal-cord-injury/
A 15 minute podcast interview with the lead author: https://www.thelancet.com/pb-assets/Lancet/stories/audio/lancet/2019/TL_july_2019_nerve_transfer.mp3
You're sure welcome RyanJ. Have a nice evening!
A lumbar puncture (LP) is the insertion of a needle into the spinal canal to collect and examine the fluid that surrounds the brain and spinal cord (cerebral spinal fluid). It is termed a "lumbar...
Let us hope this has been taken into consideration for the future phases of any funded trials.